| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.5M | — | +7.4% |
| Cost of Revenue | $27.0M | — | -10.1% |
| R&D Expense | $5.7M | — | +19.9% |
| SG&A Expense | $10.4M | — | -37.5% |
| Operating Income | -$39.1M | — | -7.5% |
| Pre-tax Income | -$30.2M | — | -1055.0% |
| Income Tax | $23K | — | -26.6% |
| Net Income | -$30.3M | — | -1042.2% |
| EPS (Basic) | -$0.12 | — | -1100.0% |
| EPS (Diluted) | -$0.12 | — | -1100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $219.0M | -7.9% | -27.3% |
| Accounts Receivable | $12.5M | +5.7% | +20.2% |
| Current Assets | $243.3M | -8.0% | -23.3% |
| Total Assets | $311.2M | -7.6% | -20.4% |
| Current Liabilities | $51.7M | +14.3% | +61.4% |
| Total Liabilities | $61.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.6M | — | -14.6% |
| Capital Expenditures | $1.1M | — | +731.2% |
| Investing Cash Flow | -$2.3M | — | +88.6% |
| Financing Cash Flow | $463 | — | -100.0% |
| Free Cash Flow | -$17.7M | — | -21.1% |
| +18.9% |
| Stockholders' Equity | $249.9M | -9.1% | -26.4% |